The increasing prevalence of obesity and diabetes is an urgent worldwide health challenge. Now in Cell Stem Cell, Yue et al. (2017) report a proof-of-concept study using genetically engineered skin transplants that produce the incretin GLP-1 to prevent diet-induced obesity, suggesting a powerful approach for treating metabolic disorders.

中文翻译：

---

使用瘦基因工程皮肤。

肥胖和糖尿病的患病率上升是全球范围内迫在眉睫的健康挑战。现在在Cell Stem Cell中，Yue等人。（2017）报告了一项概念验证研究，该研究使用基因工程皮肤移植产生降钙素GLP-1来预防饮食引起的肥胖症，从而提出了治疗代谢紊乱的有效方法。